GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3420
Submission : 1978-10-25
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20527
Submission : 2007-05-11
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3420
Submission : 1978-10-25
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20527
Submission : 2007-05-11
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : TADALAFIL
Dosage Form : TABLET; ORAL
Application Number : 206286
Country : US
Patented : No

Drug : LOPERAMIDE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 21855
Country : US
Patented : No

Drug : TRAVOPROST
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 91340
Country : US
Patented : No

Drug : FENOFIBRATE
Dosage Form : TABLET; ORAL
Application Number : 217732
Country : US
Patented : No

Drug : FELODIPINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90365
Country : US
Patented : No

Drug : LIDOCAINE AND PRILOCAINE
Dosage Form : CREAM; TOPICAL
Application Number : 76290
Country : US
Patented : No

Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65110
Country : US
Patented : No

Drug : FELODIPINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 203983
Country : US
Patented : No

Drug : NEORAL
Dosage Form : CAPSULE; ORAL
Application Number : 50715
Country : US
Patented : No

Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65017
Country : US
Patented : No

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : DENTAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 1
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : OPHTHALMIC
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 0.5
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : OPHTHALMIC
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 0.5
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : ORAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 200
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : ORAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 405
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : ORAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 450
Potency Unit : MG/1ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : ORAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 25
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : ORAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 50
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : ORAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 25
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYOXYL 40 HYDROGENATED CASTOR OIL
Route : TOPICAL
CAS : 61788-85-0
UNII : 7YC686GQ8F
Potency Amount : 1
Potency Unit : %W/W

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE